Scinai Immunotherapeutics Ltd (SCNI) News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal

Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal PR Newswire JERUSALEM...

Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG

Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development...

Biotech Rips Following Five-Year Master Service Agreement Release

There is something about biotech companies that seems to get everyone excited in the penny stock realm. Whether it’s the potential for major...

Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services

Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP...

Scinai leadership to attend BIO-Europe Spring 2024

Scinai leadership to attend BIO-Europe Spring 2024 PR Newswire JERUSALEM, March 12, 2024 Showcasing Company's...

Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024

Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024 PR Newswire JERUSALEM...

Scinai Welcomes Liat Halpert as Head of Business Development and Sales

Scinai Welcomes Liat Halpert as Head of Business Development and Sales PR Newswire JERUSALEM, Feb. 13, 2024...

Form F-3 - Registration statement by foreign private issuers

Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize

Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form D - Notice of Exempt Offering of Securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]